Making progress is the key , I believe it won't be long before they ship out they previously stated Richmond would not wait for large volumes to ship out but would ship small batches as soon as they were ready . Cant remember where I saw that without looking back. I feel good about things delays are behind us it seems and now things are moving along very well and we are making our own anode for the battery which Simon says brings in the revenue for us .(" Simon says "so it has to happen ) LOL . Imagine if we were to have stayed with NDSU if that worked out the revenue potential for Coretec would be far less. I like what Coretec is doing though its taken a lot longer to get there for several reasons but I see things now working out better for us . We may see a merger / acquisition in the near term but I'm not worried about the dilution of the stock we will see. The Coretec / 3Dicon merger brought lots of dilution and a reverse split but we were at .0002 to .0007 area and Coretec had to get a whopping 12 billion shares and 3Dicon had 1.4 billion outstanding so this is an entirely different scenario now . With good news we may jump up in stock price near term . We need it !! When the Richmond deal came about I remember they said Evonik is still our supplier of choice or something like that .
From the call :
We’ve made progress in our domestic production of CHS. As we previously mentioned, we partnered with Richmond Chemical to produce CHS at scale. The goal is to not only produce CHS, but to produce it at large quantities at a reasonable cost. Our agreement with Richmond is multi phased. The first phase is to refine and streamline the process to manufacture CHS in larger quantities. Right from the start, we ran into supply chain issues, which slowed the launch of our program by several weeks. For example, they had problems sourcing diethyl ether and other fairly common chemicals. We have overcome those issues and are now in the first phase, which is refining the CHS synthesis process so it can be produced at large
scale. To date, Richmond has made CHS, but not at the quantities we need.
We have regular meetings with Richmond. They share their laboratory notes and data. In addition, Dr. Michelle Tokarz has traveled to the production facility and met with the production team. Combined with our hands-on work in our laboratory, we are working collaboratively with Richmond to standardize the CHS synthesis process and manufacture CHS at scale.
